Management of penicillamine nephropathy in Wilson's disease: a new chelating agent

Lancet. 1969 Dec 27;2(7635):1401-2. doi: 10.1016/s0140-6736(69)90940-4.
No abstract available

MeSH terms

  • Adolescent
  • Chelating Agents / therapeutic use*
  • Chlorides
  • Copper / metabolism
  • Ethylenediamines / therapeutic use*
  • Hepatolenticular Degeneration / drug therapy*
  • Humans
  • Male
  • Nephrotic Syndrome / chemically induced*
  • Neurologic Manifestations
  • Penicillamine / adverse effects*

Substances

  • Chelating Agents
  • Chlorides
  • Ethylenediamines
  • Copper
  • Penicillamine